The PAPILLON Study is evaluating the safety and effectiveness of an investigational medication in combination with chemotherapy. Participants in this study need to have a rare form of EGFR mutation called an Exon 20 insertion. Learn more about the PAPILLON research study here.
If you are not sure which research study is for you, take this short survey to find out.
If you want to learn how biomarker testing can determine mutation types, visit this page.
This website includes information about clinical research studies in Australia. To see a list of participating countries please visit this page.
Below is a list of currently participating countries for the Mariposa and Papillon clinical research studies. For more information, please visit ClinicalTrials.gov.
Asia & Pacific
South / Latin America